We synthesized customized double-stranded DNA microarrays including methyl-5-cytosine at CpG dinucleotides and produced all 163,555 possible 8-mers (un-, hemi-, and di-methylated) to gain insight into how methylation affects transcription factor binding. An antibody to methyl-5-cytidine showed greater binding to the methylated DNA, demonstrating efficient incorporation of methyl-5-cytosine into the synthesized DNA. In contrast, binding of the transcription factor CREB was inhibited by CpG methylation. This platform represents a powerful new technology to evaluate the effect of DNA methylation on protein binding in any sequence context.
Introduction
The binding of transcription factors (TFs) to specific DNA sequences is critical for the precise control of gene expression.
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Determining the DNA binding specificity of TFs is an evolving process. Twenty years ago, PCR based selection procedures were developed that identified a small set of DNA sequences that were best bound by a TF. 3 More recently, investigators have used microarrays containing hundreds of thousands of double stranded DNA sequences to determine the binding preference of a TF to a multitude of DNA sequences, leading to the detection of many suboptimal DNA sequences that may be biologically important. 4, 5 In mammalian systems, the epigenetic differences between cell types and pathological states can be mediated by differences in methylation of the cytosine that occurs in CpG dinucleotides. 6 Methyl-5-cytosine, described by some as the fifth DNA base, is an epigenetic mark that regulates both gene activation and suppression. 7 However, the effect of CpG methylation on the binding affinity of TFs for all DNA sequences is unclear.
To determine how CpG methylation affects the DNA binding of TFs to multiple DNA sequences, we fabricated DNA microarrays containing methyl-5-cytosine only when it occurred in the CpG dinucleotide. These microarrays contain 163,555 doublestranded features which are all possible 8-mers including all 65,536 (4 8 ) unmethylated 8-mers and 98,019 hemi-methylated and di-methylated versions of each 8-mer that contains one or more CpG dinucleotides.
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Materials and methods
Microarray synthesis
SuperClean glass slides (Arrayit) were incubated in buffered silane (1.5% N-(3-triethoxysilylpropyl)-4-hydroxybutyramide (Gelest), 95% ethanol, 0.1% glacial acetic acid) with shaking for 4 h, according to current protocols. 8 After silane coating, slides were rinsed in wash solution (95% ethanol, 0.1% glacial acetic acid) with shaking for 20 min. Silanized slides were dried at 120 C for 1 h and then baked in a vacuum oven at 120 C for 12 h. Silanized slides were stored dessicated at room temperature until use for synthesis. DNA was synthesized on the silanized slides using MAS units connected to Expedite DNA synthesizers (Applied Biosystems). Two grams of photolabile NPPOC methyl-5-cytosine (Sigma-Aldrich) were used in conjunction with the other four photolabile phosphoramidites (NPPOC adenosine, NPPOC cytosine, NPPOC guanine, NPPOC thymine) (Nimblegen Systems). All phosphoramidites were diluted to 0.1M in acetonitrile and used with standard DNA synthesisgrade reagents (Sigma-Aldrich, Fisher Scientific, Nimblegen Systems) to synthesize the microarrays using standard protocols. 9 After synthesis, the base-protecting groups were removed by immersing arrays in a 1 : 1 v/v solution of ethylenediamine/ ethanol (Sigma-Aldrich) for 2 h. The arrays were rinsed in water, dried, and stored desiccated at room temperature until use.
Protein purification
The CREB leucine zipper (B-ZIP) DNA binding domain was expressed in the E. coli BL21 (LysE) strain and purified as described previously. (YPYDVPDYA) was added to the N-terminus of the B-ZIP domain for immuno-detection. HPLC using Vydac C18 reverse phase column was used for final protein purification, where a linear gradient from 0-100% acetonitrile containing 0.1% trifluoroacetic acid over 45 min with a flow rate of 1 ml min À1 was used to elute the proteins.
Electrophoretic mobility shift assay (EMSA)
The 28-mer oligonucleotides (Sigma-Aldrich) were PAGE purified. Top strand oligonucleotide was end-labeled with g-32 P ATP using T4 phage polynucleotide kinase. The labeled oligonucleotide was purified using a G-50 column (GE Healthcare) according to manufacturer instructions and annealed to the unlabeled bottom strand oligonucleotide. CREB was mixed with 7 pM 32 Pradiolabeled double-stranded oligonucleotides in the gel shift buffer (0.5 mg ml À1 BSA, 10% glycerol, 2.5 mM DTT, 12.5 mM K 2 HPO 4 -KH 2 PO 4 , pH 7.4, 0.25 mM EDTA, 10 ng ml À1 poly(dIdC)). The final volume of the reaction was adjusted to 20 ml, and incubated at 37 C for 10 min, followed by cooling at room temperature for 5 min. 10 ml samples were resolved on 7.5% PAGE at 150 V for 1.5 h in the 1x TBE buffer (25 mM Tris-boric acid, 0.5 mM EDTA). Sequences of oligonucleotides used for EMSA experiments were:
Top:
Underlined nucleotides are the consensus CREB binding site.
Microarray experiments
Methyl-5-cytidine antibody binding. Arrays were blocked with 2.5% non-fat dried milk for 1.5 h prior to protein incubation. Methyl-5-cytidine antibody (Abcam ab10805) was diluted 1 : 1000 and mixed with a 1 : 2000 dilution of a fluorescentlylabeled Cyanine 5 secondary antibody (Abcam) in mAb buffer (50 mM NaCl, 10 mM Tris-HCl pH 7.4, 1 mM MgCl 2 , 0.5 mM EDTA). The antibody mixture was added to the hybridization chamber on the array and incubated for 1 h at room temperature with constant rotation. The arrays were washed with non-stringent wash buffer (6X SSPE pH 7.5, 0.01% Tween-20), dried, and visualized using an Axon 4000B 5 mm scanner (Molecular Devices). Data was viewed using GenePixÔ Pro 6.0 microarray analysis software (Molecular Devices).
CREB binding. Arrays were blocked with 2.5% non-fat dried milk for 1.5 h prior to protein incubation. CREB was heated at 65 C for 15 min in CD buffer (12.5 mM phosphate buffer, pH 7.4, 0.25 mM EDTA, 1 mM DTT), and cooled at room temperature for 5 min. The protein was then diluted to a final concentration of 50 nM, and mixed with a directly-labeled fluorescent antibody to the HA tag of the protein, HA-TRITC (Sigma-Aldrich), in the binding buffer (10% glycerol, 12.5 mM phosphate buffer, pH 7.4, 0.25 mM EDTA, 2.5 mM DTT, 150 mM KCl, 0.5 mg ml À1 BSA, 2 ng ml À1 HA-TRITC, 0.25% milk, 0.005% Tween-20). The protein-antibody mixture was added to the hybridization chamber on the array and incubated for 1 h at room temperature with constant rotation. Subsequently, the arrays were washed first with the binding buffer, and then with the non-stringent wash buffer, dried, and visualized using an Axon GenePix 4000B 5 mm scanner. Data was viewed using the GenePixÔ Pro 6.0 microarray analysis software.
Data normalization
For each array, local mean normalization 11 was used to ensure the intensity was evenly distributed throughout each sector of the microarray surface. Complementary unmethylated sequences were averaged together. Corresponding 3 0 (3 0 H) and 5 0 (5 0 H) hemi-methylated sequences were averaged together given that the methyl-5-cytidine antibody is unaffected by unmethylated sequence context (Fig. 2) and the CREB homodimer binds equivalently to 5 0 H or 3 0 H sequences (Fig. 3d) . Non-specific binding for CREB was accounted for by subtracting aggregate single-stranded DNA intensities. Motif searching was conducted using MEME/MAST System Motif Discovery and Search (http://meme.sdsc.edu/meme/intro.html) on the 100 highest intensity/affinity sequences.
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Results and discussion
Fabrication of methyl-5-cytosine microarray
Microarrays were synthesized using a Maskless Array Synthesizer (NimbleGen Systems, Madison, WI).
0 -nitrophenylpropyloxycarbonyl (NPPOC) methyl-5-cytosine was purchased from Sigma-Aldrich. Homopolymer (T 5 ) linkers were covalently attached to monohydroxysilane glass slides and oligonucleotides were synthesized on the homopolymers to create a high-density oligonucleotide microarray. Each feature on the microarray represented a different sequence and was composed of approximately 10 6 identical synthesized probes. The synthesized DNA was 32 nucleotides long and designed to become double stranded. Hairpins were induced by incubation with 7M urea in phosphate buffered saline (PBS) for 30 min at 65 C and then in PBS for 15 min at 65 C 4,8 ( Fig. 1) .
Experimental validation
To evaluate whether the methyl-5-cytosine was incorporated into DNA during the synthesis, we examined if an antibody to methyl-5-cytidine preferentially bound to the methylated DNA. This antibody was raised against methyl-5-cytosine in an oligonucleotide context and discriminates against both unmodified cytidine and hydroxy-5-methylcytidine. 13 Binding of the antibody on the methyl-5-cytosine microarray was visualized using a fluorescently-labeled secondary antibody. Fig. 2a shows that the methyl-5-cytidine antibody preferentially bound to DNA containing di-methylated CpGs, followed by hemi-methylated CpGs with the least binding occurring to CpG containing DNA that is unmethylated. The antibody binding to the unmethylated DNA probes was low which we suggest represents non-specific binding. Position weight matrices (PWMs), shown as logos, were created from the best bound probes on the microarray using the MEME motif-finding algorithm. We produced a PWM for the antibody binding to three kinds of DNA sequences: unmethylated, hemi-methylated and di-methylated DNA 8-mers. No PWM was observed for the unmethylated probes. When the hemi-methylated or di-methylated probes were included with the unmethylated probes, the CpG dinucleotide was produced, thus confirming the specificity of the antibody (Fig. 2b) . The binding intensity to methylated probes showed a range of intensities. We evaluated if the stronger binding represented binding to probes with a larger number of methyl CpGs. We observed a linear relationship between the binding intensities and the number of methylated cytosines per probe for both the hemi-methylated and di-methylated probes (Fig. 2c) . Specifically, the antibody exhibited an increase in average normalized intensity of 0.67 per methylated cytosine for hemi-methylated DNA (inverse of the slope) and 0.81 for di-methylated DNA (inverse of the slope divided by two due to symmetrically methylated cytosines per dimethylated CpG). An analysis of the placement of the methyl CpG within the 8-mer showed no preference of the antibody to a particular CpG location (Fig. 2d) . In addition, the equivalent binding of the antibody regardless of whether the methyl-5-cytosine was incorporated early or late in the synthesis (Fig. 2d) confirmed that methyl-5-cytosine incorporation does not compromise subsequent synthesis of the DNA probe. Finally, we observed that the methyl-5-cytidine antibody recognizes a single methyl-5-cytosine epitope 14 without steric occlusion between adjacent methylated CpG sites.
Effect of cytosine methylation on CREB specificity
We next used these microarrays to examine the binding of the CREB DNA binding domain, a protein where CpG methylation is known to inhibit DNA binding. 7, 15 By visualizing binding to the microarray using a fluorescently labeled antibody to an HA epitope tag on CREB, we observed that CREB preferentially binds to the unmethylated DNA compared to the di-methylated DNA with intermediate binding to the hemi-methylated DNA. This suggests that CpG methylation globally inhibits CREB binding (Fig. 3a) . These data also confirmed a previous report examining specific DNA sequences 7 (Fig. 3b) . The unmethylated consensus CREB binding site termed the CRE (TGACGTCA) was the best-bound sequence on the array. When the top 100 sequences were examined, a CRE-like logo was observed (Fig. 3c) . However, when hemi-and di-methylated DNA were examined, no logo was observed suggesting that CpG methylation abolishes sequence specific DNA binding. To verify the microarray data, we performed electrophoretic mobility shift assays (EMSAs) using CREB. The results validated the microarray data that CREB preferentially binds to unmethylated DNA as compared to di-methylated DNA and binds hemimethylated DNA with intermediate affinity (Fig. 3d) . When we examined if the position of the methylated CpG in CREB binding sites affects CREB binding, we observed that methylation is universally detrimental to binding (Fig. 3e) .
Conclusions
This technology will allow for a global examination of the effect of CpG methylation on DNA binding of both naturally occurring DNA binding proteins and synthetic molecules with potentially important therapeutic properties. Though we have only examined the methylation of cytosine in the context of the CpG dinucleotide, this technology can also examine how cytosine methylation in additional DNA sequence contexts, as occurs in embryonic stem cells and plants, 16, 17 modulates protein binding.
